Goh 1996.
Clinical features and settings | Routine screening | |
Participants | 11,964 participants Singapore ‐ University Hospital 1989 to 1992 Pregnant women Singleton pregnancies Median maternal age 35 years (mean 33 years) 12‐22 weeks' gestation |
|
Study design | Cohort | |
Target condition and reference standard(s) | Down's syndrome: 34 cases Reference standards: karyotyping or follow‐up to birth |
|
Index and comparator tests | Maternal age First trimester and second trimester AFP and hCG (EIA method, kits from Abbot Laboratory, USA) and uE3 (In‐house indirect, extraction radioimmunoassay) Risk cut‐points of 1:250 and 1:384 |
|
Follow‐up | No details of methods of follow‐up | |
Aim of study | To appraise the potential effectiveness of implementing a prenatal screening programme on a local population in Singapore | |
Test characteristics | ||
Reference standard used | ||
Notes | ||
Table of Methodological Quality | ||
Item | Authors' judgement | Description |
Representative spectrum? All tests | Yes | Routine screening of typical pregnant population |
Acceptable reference standard? All tests | Yes | Karyotyping or follow‐up to birth |
Partial verification avoided? All tests | Unclear | Unclear if all women received a reference standard |
Differential verification avoided? All tests | No | Choice of reference standard depended on index test results |
Incorporation avoided? All tests | Yes | Reference standard was independent of the index test |
Reference standard results blinded? All tests | No | Reference standard interpreted with knowledge of index test results |
Index test results blinded? All tests | Yes | Index test interpreted without knowledge of reference standard results |
Relevant clinical information? All tests | Yes | Information available as would be in standard clinical practice |
Uninterpretable results reported? All tests | No | No details given for test failures/uninterpretable measurements |
Withdrawals explained? All tests | No | No details of withdrawals given |